Reaction Details Report a problem with these data
Target
Arginase-2, mitochondrial
Ligand
BDBM642289
Substrate
n/a
Meas. Tech.
Inhibition of Arginase
IC50
56.0±n/a nM
Citation
 Kurhade, S; Dömling, A Arginase inhibitors US Patent  US11845767 Publication Date 12/19/2023 
Target
Name:
Arginase-2, mitochondrial
Synonyms:
ARG2 | ARGI2_HUMAN | Arginase II | Kidney-type arginase | Non-hepatic arginase | Type II arginase
Type:
PROTEIN
Mol. Mass.:
38576.93
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978892
Residue:
354
Sequence:
MSLRGSLSRLLQTRVHSILKKSVHSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREGGHIVYDQLPTPSSPDESENQARVRI
  
Inhibitor
Name:
BDBM642289
Synonyms:
(5-amino-5-(1-(2-((2,3- difluorobenzyl)amino)-2-oxoethyl)-1H- tetrazol-5-yl)pentyl)boronic acid | US11845767, Example 334
Type:
Small organic molecule
Emp. Form.:
C15H21BF2N6O3
Mol. Mass.:
382.173
SMILES:
NC(CCCCB(O)O)c1nnnn1CC(=O)NCc1cccc(F)c1F
Structure:
Search PDB for entries with ligand similarity: